| Literature DB >> 26280398 |
Yunben Yang1, Yongfu Shao2, Mengying Zhu1, Qier Li2, Fang Yang1, Xuwen Lu1, Chunjing Xu1, Bingxiu Xiao1, Yanke Sun3, Junming Guo4.
Abstract
Long noncoding RNAs (lncRNAs) play vital roles in tumorigenesis. However, the diagnostic values of most lncRNAs are largely unknown. To investigate whether gastric juice lncRNA-ABHD11-AS1 can be a potential biomarker in the screening of gastric cancer, 173 tissue samples and 130 gastric juice from benign lesion, gastric dysplasia, gastric premalignant lesions, and gastric cancer were collected. ABHD11-AS1 levels were detected by reverse transcription-polymerase chain reaction. Then, the relationships between ABHD11-AS1 levels and clinicopathological factors of patients with gastric cancer were investigated. The results showed that ABHD11-AS1 levels in gastric cancer tissues were significantly higher than those in other tissues. Its levels in gastric juice from gastric cancer patients were not only significantly higher than those from cases of normal mucosa or minimal gastritis, atrophic gastritis, and gastric ulcers but also associated with gender, tumor size, tumor stage, Lauren type, and blood carcinoembryonic antigen (CEA) levels. More importantly, when using gastric juice ABHD11-AS1 as a marker, the positive detection rate of early gastric cancer patients was reached to 71.4 %. Thanks to the special origin of gastric juice, these results indicate that gastric juice ABHD11-AS1 may be a potential biomarker in the screening of gastric cancer.Entities:
Keywords: ABHD11-AS1; Gastric cancer; Gastric juice; Gene diagnosis; Long noncoding RNA; Tumor marker
Mesh：
Substances：
Year: 2015 PMID： 26280398 DOI： 10.1007/s13277-015-3903-3
Source DB: PubMed Journal: Tumour Biol ISSN： 1010-4283